Mimount Bourfiss
Overview
Explore the profile of Mimount Bourfiss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Ham W, Meijboom E, Ligtermoet M, Monshouwer-Kloots J, Te Riele A, Asselbergs F, et al.
Stem Cell Res Ther
. 2024 Dec;
15(1):470.
PMID: 39695883
Introduction: A healthy young woman, age 26 without prior cardiac complications, experienced an out-of-hospital cardiac arrest caused by ventricular fibrillation (VF), which coincided with a fever. Comprehensive diagnostics including echo,...
2.
Verheul L, Guglielmo M, Hirsch A, Figliozzi S, van der Harst P, Bourfiss M, et al.
Heart Rhythm
. 2024 Nov;
PMID: 39613201
No abstract available.
3.
Rekker L, Muller S, Gasperetti A, Bourfiss M, Oerlemans M, Cramer M, et al.
J Cardiovasc Magn Reson
. 2024 Jul;
26(2):101059.
PMID: 38986843
Background: While late gadolinium enhancement (LGE) is proposed as a diagnostic criterion for arrhythmogenic right ventricular cardiomyopathy (ARVC), the potential of LGE to distinguish ARVC from differentials remains unknown. We...
4.
Kloosterman M, Boonstra M, Roudijk R, Bourfiss M, van der Schaaf I, Velthuis B, et al.
Europace
. 2023 Jul;
25(7).
PMID: 37433034
Aims: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive inherited cardiac disease. Early detection of disease and risk stratification remain challenging due to heterogeneous phenotypic expression. The standard configuration of...
5.
Schmidt A, Bourfiss M, Alasiri A, Puyol-Anton E, Chopade S, van Vugt M, et al.
Sci Adv
. 2023 May;
9(17):eadd4984.
PMID: 37126556
Dysfunction of either the right or left ventricle can lead to heart failure (HF) and subsequent morbidity and mortality. We performed a genome-wide association study (GWAS) of 16 cardiac magnetic...
6.
van der Voorn S, Bourfiss M, Muller S, Cimen T, Saguner A, Duru F, et al.
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979791
Arrhythmogenic cardiomyopathy (ACM) is a progressive inheritable disease which is characterized by a gradual fibro-(fatty) replacement of the myocardium. Visualization of diffuse and patchy fibrosis patterns is challenging using clinically...
7.
Schmidt A, Finan C, Bourfiss M, Velthuis B, Puyol-Anton E, Alasiri A, et al.
Res Sq
. 2023 Feb;
PMID: 36778476
Background: drug development and disease prevention of heart failure (HF) and atrial fibrillation (AF) are impeded by a lack of robust early-stage surrogates. We determined to what extent cardiac magnetic...
8.
Bourfiss M, van Vugt M, Alasiri A, Ruijsink B, van Setten J, Schmidt A, et al.
Circ Genom Precis Med
. 2022 Oct;
15(6):e003704.
PMID: 36264615
Background: Pathogenic and likely pathogenic variants associated with arrhythmogenic right ventricular cardiomyopathy (ARVC), dilated cardiomyopathy (DCM), and hypertrophic cardiomyopathy (HCM) are recommended to be reported as secondary findings in genome...
9.
Bourfiss M, Sander J, de Vos B, Te Riele A, Asselbergs F, Isgum I, et al.
Clin Res Cardiol
. 2022 Sep;
112(3):363-378.
PMID: 36066609
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is diagnosed according to the Task Force Criteria (TFC) in which cardiovascular magnetic resonance (CMR) imaging plays an important role. Our study aims to...
10.
Cadrin-Tourigny J, Bosman L, Nozza A, Wang W, Tadros R, Bhonsale A, et al.
Eur Heart J
. 2022 Apr;
43(32):e1-e9.
PMID: 35441664
Aims: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) is characterized by ventricular arrhythmias (VAs) and sudden cardiac death (SCD). We aimed to develop a model for individualized prediction of incident VA/SCD in...